Established in 1992, IBSA Farmaceutici Italia, the Group's main subsidiary in the world, has its headquarters in Lodi, where ... the first production plant was also established. Over the years, IBSA has grown rapidly through the addition of the Rome headquarters and the Cassina dè Pecchi (MI) production plant and becoming a leading economic and scientific reality in the Italian pharmaceutical sector. Currently IBSA employs more than 500 people in Italy and has 65 active patents on cutting-edge pharmaceuticals technologies. Technology and expertise, together with R&D investments, have allowed the Company to build up over time a wide product portfolio in 12 therapeutic areas. Pharmaceutical products, medical devices, consumer products and food supplements, developed and produced in Italy by our People and sold in more than 80 countries worldwide. IBSA leverages advanced technologies for the study of innovative methods in the administration of drugs - such as pre-filled syringes, softgels, orodispersible films (ODF), patches (Hydrogel and Tape) and ointments in BOV (Bag on Valve) - with the aim of providing healthcare professionals with new therapeutic solutions, effective and reliable, enhancing the quality of life of patients. The pillars of IBSA are people, innovation and sustainability. We rely on LinkedIn to connect with global partners for business partnerships, new product development and contract manufacturing. If you have good ideas, contact us to realize them together. read more